Ausgabe 2/2017
Inhalt (23 Artikel)
Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)—report on phases I and II
Martha Groth, Susanne Singer, Cathrin Niedeggen, Andrea Petermann-Meyer, Alexander Röth, Hubert Schrezenmeier, Britta Höchsmann, Tim H. Brümmendorf, Jens Panse
The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan
Hui-Ching Wang, Li-Ling Hsieh, Yi-Chang Liu, Hui-Hua Hsiao, Shu-Kai Lin, Wen-Chan Tsai, Ta-Chih Liu
Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential
Phatchanat Klaihmon, Kunwadee Phongpao, Wasinee Kheansaard, Egarit Noulsri, Archrob Khuhapinant, Suthat Fucharoen, Noppawan Phumala Morales, Saovaros Svasti, Kovit Pattanapanyasat, Pornthip Chaichompoo
Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin
Luise Burkhardt, Stephan Lobitz, Elisabeth Koustenis, Stefan Mark Rueckriegel, Pablo Hernáiz Driever
Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis
Wanhua Zhang, Pu Kuang, He Li, Fengjuan Wang, Yu Wang
Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP
Duo Liu, Yuhui Wang, Mei Dong, Shangwei Guan, Yan Wang, Haiming Sun, Nan Wu, Su Li, Jing Bai, Feng Chen, Donglin Sun, Yan Jin
Peripheral blood lymphocyte/monocyte ratio following completion of first-line therapy predicts early relapse in patients with diffuse large B cell lymphoma
Shu-Juan Zhou, Yong-Yong Ma, Yu Zhang, Sheng Luo, Li-Yuan Tang, Yi Chen, Lan Sun, Kang Yu
Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified
Fei Qi, Mei Dong, Xiaohui He, Yexiong Li, Weihu Wang, Peng Liu, Jianliang Yang, Lin Gui, Changgong Zhang, Sheng Yang, Shengyu Zhou, Yuankai Shi
Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone
Bruce D. Cheson, Peter C. Trask, John G. Gribben, Natalie Dimier, Eva Kimby, Pieternella J. Lugtenburg, Catherine Thieblemont, Elisabeth Wassner-Fritsch, Aino Launonen, Laurie H. Sehn
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
Ebba K. Lindqvist, Ola Landgren, Sigrún H. Lund, Ingemar Turesson, Malin Hultcrantz, Lynn Goldin, Magnus Björkholm, Sigurdur Y. Kristinsson
Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study
Yael C Cohen, Tsila Zuckerman, Moshe Yeshurun, Galit Perez, Hila Magen, Israel Henig, Itai Levi, Liat Shargian, Svetlana Trestman, Uri Rouvio, Elizabeth Naparstek, Eti Ganon-Elazar, Irit Avivi, Ron Ram
The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Group
Chang-Lin Yu, Zheng-Dong, Zhen-Hua Qiao, Jian-Min Wang, Huang-He, Ying-Min Liang, De-Pei Wu, Bao-An Chen, Bai-Hai, Bao-Fu Shi, Wan-Jun Sun, Jun-Xiao Qiao, Mei Guo, Jian-Hui Qiao, Qi-Yun Sun, Kai-Xun Hu, Ya-Jing Huang, Hong-li Zuo, Xiao-Jun Huang, Hui-Sheng Ai
Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia
Satoshi Yamasaki, Akihiro Hirakawa, Jun Aoki, Naoyuki Uchida, Takahiro Fukuda, Hiroyasu Ogawa, Kazuteru Ohashi, Tadakazu Kondo, Tetsuya Eto, Heiwa Kanamori, Hirokazu Okumura, Koji Iwato, Tatsuo Ichinohe, Junya Kanda, Makoto Onizuka, Yachiyo Kuwatsuka, Masamitsu Yanada, Yoshiko Atsuta, Akiyoshi Takami, Shingo Yano
Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset
E.-M. Bohmann, U. Fehn, B. Holler, D. Weber, E. Holler, W. Herr, P. Hoffmann, M. Edinger, D. Wolff
Predicting risk factors for varicella zoster virus infection and postherpetic neuralgia after hematopoietic cell transplantation using ordered logistic regression analysis
Yuko Kanbayashi, Yosuke Matsumoto, Junya Kuroda, Tsutomu Kobayashi, Shigeo Horiike, Toyoshi Hosokawa, Masafumi Taniwaki
Calreticulin mutations are exceedingly rare in patients with myelodysplastic syndromes with myelofibrosis
Julia Montoro, Cristina Robledo, Lurdes Zamora, David Valcárcel, Fernando Ramos
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Kenichiro Hattori, Noriko Doki, Shuhei Kurosawa, Yutaro Hino, Keita Yamamoto, Masahiro Sakaguchi, Kaito Harada, Shuntaro Ikegawa, Naoki Shingai, Yasushi Senoo, Aiko Igarashi, Yuho Najima, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi
Outcome of allogeneic hematopoietic stem cell transplantation in cases of mature T/NK-cell neoplasms: a single-center retrospective analysis
Hiroyuki Yamazaki, Kazunari Aoki, Tadakazu Kondo, Momoko Nishikori, Toshiyuki Kitano, Masakatsu Hishizawa, Kouhei Yamashita, Akifumi Takaori-Kondo
HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab
Makoto Hirosawa, Takehiro Higashi, Atsushi Iwashige, Takahiro Yamaguchi, Junichi Tsukada
The importance of erythroblast enumeration in myeloid neoplasia
Amer M. Zeidan, Mina Xu, David P. Steensma
High serum levels of complements C3 and C4 as novel markers for myeloma bone disease
Fengjuan Jiang, Hui Liu, Zhaoyun Liu, Jia Song, Lijuan Li, Kai Ding, Yue Ren, Fengping Peng, Zonghong Shao, Rong Fu
BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib
Heiblig Maël, Bidet Audrey, Callet-Bauchu Evelyne, Dumas Pierre-Yves, Chabane Kaddour, Salles Gilles, Pigneux Arnaud
Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib
Maël Heiblig, Audrey Bidet, Evelyne Callet-Bauchu, Pierre-Yves Dumas, Kaddour Chabane, Gilles Salles, Arnaud Pigneux